ATE424411T1 - Varianten von säugerprolactin - Google Patents
Varianten von säugerprolactinInfo
- Publication number
- ATE424411T1 ATE424411T1 AT03729258T AT03729258T ATE424411T1 AT E424411 T1 ATE424411 T1 AT E424411T1 AT 03729258 T AT03729258 T AT 03729258T AT 03729258 T AT03729258 T AT 03729258T AT E424411 T1 ATE424411 T1 AT E424411T1
- Authority
- AT
- Austria
- Prior art keywords
- variants
- prolactin
- mammal
- prl
- mutations
- Prior art date
Links
- 108010057464 Prolactin Proteins 0.000 title abstract 4
- 102000003946 Prolactin Human genes 0.000 title abstract 4
- 229940097325 prolactin Drugs 0.000 title abstract 4
- 241000124008 Mammalia Species 0.000 title abstract 3
- 230000035772 mutation Effects 0.000 abstract 4
- 101001123448 Homo sapiens Prolactin receptor Proteins 0.000 abstract 2
- 108010002519 Prolactin Receptors Proteins 0.000 abstract 2
- 102100029000 Prolactin receptor Human genes 0.000 abstract 2
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 abstract 1
- 101100022915 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) cys-11 gene Proteins 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2257—Prolactin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57554—Prolactin
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Reproductive Health (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02290030A EP1325930A1 (de) | 2002-01-08 | 2002-01-08 | Varianten von Säugerprolactin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE424411T1 true ATE424411T1 (de) | 2009-03-15 |
Family
ID=8185691
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03729258T ATE424411T1 (de) | 2002-01-08 | 2003-01-08 | Varianten von säugerprolactin |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7785838B2 (de) |
| EP (2) | EP1325930A1 (de) |
| JP (1) | JP4324477B2 (de) |
| CN (1) | CN100358919C (de) |
| AT (1) | ATE424411T1 (de) |
| AU (1) | AU2003215539B2 (de) |
| CA (1) | CA2472647C (de) |
| DE (1) | DE60326430D1 (de) |
| ES (1) | ES2323233T3 (de) |
| MX (1) | MXPA04006676A (de) |
| WO (1) | WO2003057729A2 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1962883B1 (de) * | 2005-12-22 | 2012-10-10 | VIB, vzw | Mittel und verfahren zur vermittlung von protein-interferenz |
| JP5888832B2 (ja) * | 2005-12-22 | 2016-03-22 | フラームス・インテルウニフェルシタイル・インステイチュート・フォール・ビオテヒノロヒー・ヴェーゼットウェー（ヴェーイーベー・ヴェーゼットウェー）Ｖｌａａｍｓ Ｉｎｔｅｒｕｎｉｖｅｒｓｉｔａｉｒ Ｉｎｓｔｉｔｕｕｔ Ｖｏｏｒ Ｂｉｏｔｅｃｈｎｏｌｏｇｉｅ Ｖｚｗ（Ｖｉｂ Ｖｚｗ） | タンパク質干渉を媒介する手段および方法 |
| WO2008114077A1 (en) * | 2007-03-20 | 2008-09-25 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Constitutively active mutants of the prolactin receptor |
| EP2332995A1 (de) * | 2009-12-10 | 2011-06-15 | Bayer Schering Pharma Aktiengesellschaft | Neutralisierende Prolactinrezeptor-Antikörper und deren therapeutische Verwendung |
| EP2576823A1 (de) | 2010-06-04 | 2013-04-10 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Konstitutiv aktive prolactin-rezeptorvarianten als prognostische marker und therapeutische ziele zur vorbeugung des fortschritts von hormonabhängigen karzinomen in richtung hormonunabhängigkeit |
| US10920242B2 (en) | 2011-02-25 | 2021-02-16 | Recombinetics, Inc. | Non-meiotic allele introgression |
| US9528124B2 (en) | 2013-08-27 | 2016-12-27 | Recombinetics, Inc. | Efficient non-meiotic allele introgression |
| EP2530089A1 (de) * | 2011-06-03 | 2012-12-05 | Bayer Pharma Aktiengesellschaft | Neutralisierender Antikörper Mat3 gegen den Prolactinrezeptor und dessen therapeutische Verwendung |
| EP2846822A2 (de) * | 2012-05-11 | 2015-03-18 | Prorec Bio AB | Verfahren zur diagnose und behandlung von mit prolactin assoziierten störungen |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4767709A (en) * | 1984-06-28 | 1988-08-30 | The Johns Hopkins University | Growth-related hormones |
-
2002
- 2002-01-08 EP EP02290030A patent/EP1325930A1/de not_active Withdrawn
-
2003
- 2003-01-08 EP EP03729258A patent/EP1463758B1/de not_active Expired - Lifetime
- 2003-01-08 DE DE60326430T patent/DE60326430D1/de not_active Expired - Lifetime
- 2003-01-08 MX MXPA04006676A patent/MXPA04006676A/es active IP Right Grant
- 2003-01-08 ES ES03729258T patent/ES2323233T3/es not_active Expired - Lifetime
- 2003-01-08 WO PCT/EP2003/000448 patent/WO2003057729A2/en active Application Filing
- 2003-01-08 AU AU2003215539A patent/AU2003215539B2/en not_active Ceased
- 2003-01-08 JP JP2003558043A patent/JP4324477B2/ja not_active Expired - Fee Related
- 2003-01-08 CN CNB038033577A patent/CN100358919C/zh not_active Expired - Fee Related
- 2003-01-08 CA CA2472647A patent/CA2472647C/en not_active Expired - Fee Related
- 2003-01-08 AT AT03729258T patent/ATE424411T1/de not_active IP Right Cessation
- 2003-01-08 US US10/500,968 patent/US7785838B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005526493A (ja) | 2005-09-08 |
| AU2003215539A1 (en) | 2003-07-24 |
| CN1628128A (zh) | 2005-06-15 |
| CN100358919C (zh) | 2008-01-02 |
| DE60326430D1 (de) | 2009-04-16 |
| WO2003057729A2 (en) | 2003-07-17 |
| EP1463758B1 (de) | 2009-03-04 |
| EP1325930A1 (de) | 2003-07-09 |
| CA2472647C (en) | 2013-04-02 |
| MXPA04006676A (es) | 2005-03-31 |
| CA2472647A1 (en) | 2003-07-17 |
| AU2003215539B2 (en) | 2009-03-26 |
| JP4324477B2 (ja) | 2009-09-02 |
| US7785838B2 (en) | 2010-08-31 |
| US20060277614A1 (en) | 2006-12-07 |
| ES2323233T3 (es) | 2009-07-09 |
| WO2003057729A3 (en) | 2003-10-16 |
| EP1463758A2 (de) | 2004-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69940063D1 (de) | Biphenylsulfonamide als zweifach aktive rezeptor antagonisten von angiotensin und endothelin | |
| NO20003221D0 (no) | Ny G-proteinkoblet reseptor | |
| DE60335216D1 (de) | Adiponektin-rezeptor und dafür kodierendes gen | |
| DE60332320D1 (de) | Neues screening-verfahren | |
| EA200300441A1 (ru) | Ассоциация антагониста рецептора св1 и сибутрамина, содержащие их фармацевтические композиции и их применение для лечения ожирения | |
| EA200401309A1 (ru) | Тризамещённые гетероарилы и способы их получения и применения | |
| DK1379525T3 (da) | Heteropolycykliske forbindelser og anvendelse deraf som metabotropiske glutamatreceptor-antagonister | |
| DE69034103D1 (de) | Imidazoalkensäure | |
| ATE424411T1 (de) | Varianten von säugerprolactin | |
| EA200500173A1 (ru) | Производные 3,6-дизамещенного азабицикло[3.1.0]гексана в качестве антагонистов мускариновых рецепторов | |
| CO5460266A1 (es) | Novedosos analogos de la somatostatina | |
| PL350568A1 (en) | N-(2-phenyl-4-aminobutyl)-1-naphtamides as antagonists of neurokinin 1 receptors | |
| EA200000198A1 (ru) | 2-ациламинопропанамины в качестве антагонистов рецепторов тахикининов | |
| WO2000050563A3 (en) | G protein-coupled receptor resembling galanin receptors | |
| SE9602822D0 (sv) | New receptor | |
| ATE511644T1 (de) | Neues screening-verfahren | |
| DE602004030899D1 (de) | Neues screening-verfahren | |
| SE9804274D0 (sv) | Novel receptor | |
| ATE445159T1 (de) | Neues screening-verfahren | |
| SE9902763D0 (sv) | Novel receptor | |
| DE69936394D1 (de) | Nicht-desensibilisierende ampa-rezeptoren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |